BRC Therapeutics Appoints Biopharma Veteran Chandra Ramanathan as Executive Vice President of Commercialization and Strategy

{
  "signal_id": "07c1b125-8d4c-fe2b-8c67-120cbe86ea20",
  "signal_type": "news",
  "signal_subtype": "leaves",
  "detected_at": "2026-08-24T15:00:00+00:00",
  "company": {
    "name": "Danaher",
    "domain": "danaher.com"
  },
  "data": {
    "url": "https://www.prnewswire.com/news-releases/brc-therapeutics-appoints-biopharma-veteran-chandra-ramanathan-as-executive-vice-president-of-commercialization-and-strategy-302858352.html",
    "title": "BRC Therapeutics Appoints Biopharma Veteran Chandra Ramanathan as Executive Vice President of Commercialization and Strategy",
    "contact": "Chandra Ramanathan",
    "excerpt": "Seasoned Executive Brings Track Record of Drug Launches, External Innovation, and Portfolio Growth at Bristol Myers Squibb, Wyeth, Bayer, and Danaher to BRC's Next Phase of Growth MONTEREY, Calif. , Aug. 24, 2026 /PRNewswire/ -- BRC Therapeutics (BRC), a clinical-stage pharmaceutical company developing multimodal cannabinoid therapeutics for neurological and inflammatory conditions, today announced the appointment of Chandra Ramanathan, Ph.D., M.B.A., as Executive Vice President of Commercialization and Strategy. Ramanathan brings more than 30 years of biopharmaceutical leadership spanning drug development, global product launches, commercialization, and external innovation to BRC as the company advances its pipeline and prepares for its next phase of growth. Ramanathan joins BRC from Danaher Corporation, where he served as Vice President and Global Head of Innovation Hubs and Head of External Innovation, Life Sciences Innovation Group (LSIG) building a funnel of product-oriented partnerships across genomic medicine, diagnostics, LSIG, and biomanufacturing. Prior to Danaher, he spent more than 12 years at Bayer, most recently as Global Head of Pharma R&D Open Innovation, where he chaired the Open Innovation Committee overseeing an annual investment budget of more than $90 million across more than 50 academic and biotech partnerships. While leading Bayer's East Coast Innovation...",
    "summary": "Chandra Ramanathan has left his role as Vice President and Global Head of Innovation Hubs and Head of External Innovation, Life Sciences Innovation Group (LSIG) at Danaher Corporation to join BRC Therapeutics.",
    "planning": false,
    "image_url": "https://mmx.prnewswire.com/media/MS1675215/BRC-Logo.jpg?id=OA2905779&p=facebook",
    "job_title": "Vice President and Global Head of Innovation Hubs and Head of External Innovation, Life Sciences Innovation Group (LSIG)",
    "confidence": 0.9,
    "published_at": "2026-08-24T15:00:00Z",
    "job_title_tags": [
      "directors",
      "operations"
    ],
    "article_sentence": "Ramanathan joins BRC from Danaher Corporation, where he served as Vice President and Global Head of Innovation Hubs and Head of External Innovation, Life Sciences Innovation Group (LSIG) building a funnel of product-oriented partnerships across genomic medicine, diagnostics, LSIG, and biomanufacturing."
  }
}

curl https://signals.autobound.ai/v1/signals/07c1b125-8d4c-fe2b-8c67-120cbe86ea20 \
  -H "X-API-KEY: $AUTOBOUND_API_KEY"

curl -X POST https://signals.autobound.ai/v1/companies/enrich \
  -H "X-API-KEY: $AUTOBOUND_API_KEY" \
  -H "Content-Type: application/json" \
  -d '{"domain":"danaher.com","limit":20}'